[Retracted] Application Value of NT-proBNP Combined with NLR in Evaluation of Major Adverse Cardiac Events in Elderly Patients with Chronic Heart Failure

Table 2

Comparison of clinical data between the MACE group and non-MACE group (n,  ± s, %).

Item	Non-MACE group (n = 37)	MACE group (n = 13)	χ^2/t value	-Value
Age (years)	73.59 ± 2.51	75.77 ± 3.54	2.412	0.020
Male	22 (59.46%)	8 (61.54%)	0.017	0.895
History of coronary heart disease	21 (56.76%)	7 (53.85%)	0.033	0.856
History of diabetes	11 (29.73%)	4 (30.77%)	0.005	0.944
History of hypertension	22 (59.46%)	9 (69.23%)	0.390	0.532
WBC (×10^9/L)	6.12 ± 1.13	7.11 ± 1.66	2.393	0.021
NEU (×10^9/L)	4.65 ± 1.02	5.55 ± 1.48	2.422	0.019
LYM (×10^9/L)	1.61 ± 0.21	1.16 ± 0.19	6.802	<0.001
PLT (×10^9/L)	180.51 ± 33.03	209.23 ± 47.98	2.386	0.021
Blood glucose (mmol/L)	5.92 ± 1.22	6.99 ± 1.78	2.402	0.020
NLR	2.93 ± 0.64	5.12 ± 2.81	4.497	<0.001
NT-proBNP (pg/ml)	3669.08 ± 349.48	3973.06 ± 507.73	2.386	0.021